New method revolutionizes body composition analysis using 3D imaging and deep learning

The FDA’s On­co­log­ic Drugs Ad­vi­so­ry Com­mit­tee on Wednes­day vot­ed 14 to 6 in fa­vor of the ef­fi­ca­cy of US WorldMeds’ po­ten­tial ther­a­py to re­duce the

Tabelecleucel is an allogenic, T cell immunotherapy designed to identify and eliminate EBV-infected cells. Credits: FrentaN/Shutterstock.com Atara Biotherapeutics has announced that the US Food and

The randomised, multicentre, open-label trial enrolled 137 patients across Asia, Europe and North America. Credit: Shutterstock / Pavel Kapysh. The US Food and Drug Administration